CoChat

Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by peripheral lung fibrosis and increased interstitial extracellular matrix (ECM) deposition. In IPF, tumor growth factor (TGF)-β1 which is the major stimulus of ECM deposition, and platelet derived growth factor (PDGF)-BB is a potent stimulus of fibrosis. Thus, the effect of Treprostinil on TGF-ß1 and PDGF-induced fibroblast proliferation and ECM deposition was investigated. Human peripheral lung fibroblasts of seven IPF patients and five lung donors were stimulated by PDGF, or TGF-β1, or the combination. Cells were pre-incubated (30 min) with either Treprostinil, forskolin, di-deoxyadenosine (DDA), or vehicle. Treprostinil time dependently activated cAMP thereby preventing PDGF-BB induced proliferation and TGF-β1 secretion. Cell counts indicated proliferation; α-smooth muscle actin (α-SMA) indicted differentiation, and collagen type-1 or fibronectin deposition remodeling. Myo-fibroblast indicating α-SMA expression was significantly reduced and its formation was altered by Treprostinil. Collagen type-I and fibronectin deposition were also reduced by Treprostinil. The effect of Treprostinil on collagen type-I deposition was cAMP sensitive as it was counteracted by DDA, while the effect on fibronectin was not cAMP mediated. Treprostinil antagonized the pro-fibrotic effects of both PDGF-BB and TGF-β1 in primary human lung fibroblasts. The data presented propose a therapeutic relevant anti-fibrotic effect of Treprostinil in IPF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-19294-1

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (a) Kinetic of cellular cAMP levels in control fibroblasts (n = 5) in the presence of Treprostinil or Treprostinil+ DDA. (b) Kinetic of cellular cAMP levels in IPF fibroblasts (n = 6) in the presence of Treprostinil or Treprostinil+ DDA. (c) Secretion of active TGF-β1 24 hrs after stimulation of fibroblasts with PDGF-BB and/or Treprostinil and/or DDA. Control fibroblasts (n = 5), IPF fibroblasts (n = 7). (d) Secretion of active CTGF 24 hrs after stimulation of fibroblasts with PDGF-BB and/or Treprostinil and/or DDA. Bars show mean ± S.E.M. of triplicated experiments. Statistics: Mann-Whitney U-test.
Figure 1 (a) Kinetic of cellular cAMP levels in control fibroblasts (n = 5) in the presence of Treprostinil or Treprostinil+ DDA. (b) Kinetic of cellular cAMP levels in IPF fibroblasts (n = 6) in the presence of Treprostinil or Treprostinil+ DDA. (c) Secretion of active TGF-β1 24 hrs after stimulation of fibroblasts with PDGF-BB and/or Treprostinil and/or DDA. Control fibroblasts (n = 5), IPF fibroblasts (n = 7). (d) Secretion of active CTGF 24 hrs after stimulation of fibroblasts with PDGF-BB and/or Treprostinil and/or DDA. Bars show mean ± S.E.M. of triplicated experiments. Statistics: Mann-Whitney U-test.CC BY · PubMed Central
Figure 2 The effect of Treprostinil on PDGF-BB and TGF-β1 induced α-SMA expression. (a) Dose dependent stimulation of α-SMA expression by PDGF-BB in fibroblasts over 24 hrs as measured by immuno-blotting and densitometric analysis. Anti-pan TGF-β antibody (1 μg/ml) was added together with PDGF-BB. (b) Dose dependent stimulation of α-SMA expression by TGF-β1 in fibroblasts over 24 hrs as measured by immuno-blotting and densitometric analysis. Anti-panTGF-β antibody (1 μg/ml) was added together with PDGF-BB. (c) Dose dependent inhibition of PDGF-BB induced α-SMA secretion by Treprostinil; DDA (10 μM) was added 30 min before Treprostinil. (d) Dose dependent inhibition of TGF-β1 induced α-SMA secretion by Treprostinil; DDA (10 μM) was added 30 min before Treprostinil. Bars show the mean ± S.E.M. triplicates in all primary control and IPF cell lines. Statistics: Mann-Whitney U-test. (e) Representative immuno-blots for the effect of PDGF-BB (10 ng/ml), Treprostinil (10−6 M) and DDA (10−5 M) on the expression of α-SMA, collagen type-I and fibronectin (α-tubulin served as house keeping protein) after 42 hrs. Similar results were obtained in all other cell lines.
Figure 2 The effect of Treprostinil on PDGF-BB and TGF-β1 induced α-SMA expression. (a) Dose dependent stimulation of α-SMA expression by PDGF-BB in fibroblasts over 24 hrs as measured by immuno-blotting and densitometric analysis. Anti-pan TGF-β antibody (1 μg/ml) was added together with PDGF-BB. (b) Dose dependent stimulation of α-SMA expression by TGF-β1 in fibroblasts over 24 hrs as measured by immuno-blotting and densitometric analysis. Anti-panTGF-β antibody (1 μg/ml) was added together with PDGF-BB. (c) Dose dependent inhibition of PDGF-BB induced α-SMA secretion by Treprostinil; DDA (10 μM) was added 30 min before Treprostinil. (d) Dose dependent inhibition of TGF-β1 induced α-SMA secretion by Treprostinil; DDA (10 μM) was added 30 min before Treprostinil. Bars show the mean ± S.E.M. triplicates in all primary control and IPF cell lines. Statistics: Mann-Whitney U-test. (e) Representative immuno-blots for the effect of PDGF-BB (10 ng/ml), Treprostinil (10−6 M) and DDA (10−5 M) on the expression of α-SMA, collagen type-I and fibronectin (α-tubulin served as house keeping protein) after 42 hrs. Similar results were obtained in all other cell lines.CC BY · PubMed Central
Figure 3 (a) Treprostinil inhibits PDGF-BB induced fibronectin deposition through TGF-β1 and cAMP. (b) Treprostinil inhibits TGF-β1 induced fibronectin deposition through cAMP signaling. Bars show the mean ± S.E.M. of triplicated experiments all primary control and IPF cell lines. Statistics: Mann-Whitney U-test.
Figure 3 (a) Treprostinil inhibits PDGF-BB induced fibronectin deposition through TGF-β1 and cAMP. (b) Treprostinil inhibits TGF-β1 induced fibronectin deposition through cAMP signaling. Bars show the mean ± S.E.M. of triplicated experiments all primary control and IPF cell lines. Statistics: Mann-Whitney U-test.CC BY · PubMed Central
Figure 4 (a) Treprostinil inhibits PDGF-BB induced collagen type-I deposition through TGF-β1 and cAMP. (b) Treprostinil inhibits TGF-β1 induced collagen type-I deposition through cAMP signaling. Bars show the mean ± S.E.M. of triplicated experiments all primary control and IPF cell lines. Statistics: Mann-Whitney U-test.
Figure 4 (a) Treprostinil inhibits PDGF-BB induced collagen type-I deposition through TGF-β1 and cAMP. (b) Treprostinil inhibits TGF-β1 induced collagen type-I deposition through cAMP signaling. Bars show the mean ± S.E.M. of triplicated experiments all primary control and IPF cell lines. Statistics: Mann-Whitney U-test.CC BY · PubMed Central
Figure 5 Treprostinil prevents α-SMA and fibronectin deposition and arrangement dose dependently. (a) PDGF-BB stimulated total synthesis as well as contractile fibril confirmation of α-SMA within 24 hrs and this was dose dependently reduced by Treprostinil. Fourth row shows images of cells incubated with the secondary antibody alone and with isotype antibodies of the first α-SMA specific antibody. (b) PDGF-BB induced fibronectin synthesis and network formation was dose dependently reduced by pre-incubation (30 min) with Treprostinil. Fourth row shows images of cells incubated with the secondary antibody alone and with isotype antibodies of the first fibronectin specific antibody. All pictures are representative for at least 5 additional experiments performed in independent primary cells.
Figure 5 Treprostinil prevents α-SMA and fibronectin deposition and arrangement dose dependently. (a) PDGF-BB stimulated total synthesis as well as contractile fibril confirmation of α-SMA within 24 hrs and this was dose dependently reduced by Treprostinil. Fourth row shows images of cells incubated with the secondary antibody alone and with isotype antibodies of the first α-SMA specific antibody. (b) PDGF-BB induced fibronectin synthesis and network formation was dose dependently reduced by pre-incubation (30 min) with Treprostinil. Fourth row shows images of cells incubated with the secondary antibody alone and with isotype antibodies of the first fibronectin specific antibody. All pictures are representative for at least 5 additional experiments performed in independent primary cells.CC BY · PubMed Central
Figure 6 (a) Representative cyto-chemical staining (n = 3) for the dose-dependent reduction of PDGF-BB induced expression of α-SMA by Treprostinil at 48 hrs. (b) Representative cyto-chemical staining for the dose-dependent reduction of PDGF-BB induced expression of fibronectin (n = 3) by Treprostinil at 48 hrs. (c) Dose-dependent stimulation of fibroblast proliferation in three primary human non-fibrotic and three primary human IPF fibroblast lines (3 days). (d) Dose-dependent inhibitory effect of Treprostinil on PDGF-BB induced fibroblast proliferation in all primary control and IPF cell lines (3 days). Bars show the mean ± S.E.M. Statistics: Mann-Whitney U-test.
Figure 6 (a) Representative cyto-chemical staining (n = 3) for the dose-dependent reduction of PDGF-BB induced expression of α-SMA by Treprostinil at 48 hrs. (b) Representative cyto-chemical staining for the dose-dependent reduction of PDGF-BB induced expression of fibronectin (n = 3) by Treprostinil at 48 hrs. (c) Dose-dependent stimulation of fibroblast proliferation in three primary human non-fibrotic and three primary human IPF fibroblast lines (3 days). (d) Dose-dependent inhibitory effect of Treprostinil on PDGF-BB induced fibroblast proliferation in all primary control and IPF cell lines (3 days). Bars show the mean ± S.E.M. Statistics: Mann-Whitney U-test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 61

Metadata

Authors
Lambers, C., Roth, M., Jaksch, P., Muraközy, G., Tamm, M., Klepetko, W., Ghanim, B., & Zhao, F.
Affiliations
  • Medical University of Vienna (AT)
  • University of Basel (CH)
Corresponding author
Lambers, Christopher
Venue
Scientific Reports
Published
2018-01-18
Volume
8
Issue
1
Pages
1087-1087
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2783225214
Cited by
61
References
43
Citations by year
2026: 10 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 2 · 2018: 1
FWCI
3.01
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
treprostinil, idiopathic pulmonary fibrosis, lung fibroblasts, fibroblast proliferation, extracellular matrix deposition, cAMP signaling, TGF-β1, PDGF-BB, myofibroblast differentiation, alpha-smooth muscle actin, type I collagen, fibronectin, antifibrotic therapy
MeSH terms
Cyclic AMP, Cells, Cultured, Extracellular Matrix, Fibroblasts, Humans, Epoprostenol, Biomarkers, Cell Proliferation, Transforming Growth Factor beta1, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation. https://app.cochat.ai/papers/10.1038/s41598-018-19294-1
The paper
Lambers, C., Roth, M., Jaksch, P., Muraközy, G., Tamm, M., Klepetko, W., Ghanim, B., & Zhao, F. (2018). Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation. Scientific Reports. https://doi.org/10.1038/s41598-018-19294-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.